Skip to Main Content

Paper Details

Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
Epilepsy Res
14
2017
Author NameAffiliation
Peggy L PeissigMarshfield Clinic Research Foundation, Biomedical Informatics Research Center
Richard L BergMarshfield Clinic Research Foundation, Biomedical Informatics Research Center
  • 1 - 2

Datasets

Release 1.2